{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-003318","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.901552+00:00","generated_at":"2026-06-15T00:56:03.324863+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Predictive Oncology Q1 2023 net loss $3.4M on revenue $0.2M; partnerships announced","bullets":["Net loss of $3.4M, diluted EPS loss $0.86; revenue $239.9K vs $314.6K in Q1 2022.","Cash $18.6M vs $22.1M at Dec 31, 2022; stockholders' equity $18.6M.","Gross margin fell to 50% from 65% due to sales mix.","Partnerships: Cancer Research Horizons, Integra Therapeutics, Cvergenx announced.","Appointed Veena Rao to Board and Pamela Bush as Chief Business Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-003318","json":"https://secwatch.observer/filing/0001171843-23-003318.json","markdown":"https://secwatch.observer/filing/0001171843-23-003318.md","text":"https://secwatch.observer/filing/0001171843-23-003318.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323003318/0001171843-23-003318-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323003318/f8k_051523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:56:03.324863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e4c998cfc4ed1de08c79b48de27740ef150122b","claim":"Axe Compute Inc. reported financial results for three months ended March 31, 2023.","evidence_excerpt":"On May 15, 2023, Predictive Oncology Inc. issued a press release attached hereto as Exhibit 99.1 announcing its financial results for the three months ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323003318/0001171843-23-003318-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}